Details for Patent: 10,052,385
✉ Email this page to a colleague
Which drugs does patent 10,052,385 protect, and when does it expire?
Patent 10,052,385 protects BENDEKA and is included in one NDA.
This patent has sixty patent family members in sixteen countries.
Summary for Patent: 10,052,385
| Title: | Formulations of bendamustine |
| Abstract: | Methods of treatment using bendamustine formulations designed for small volume intravenous administration are disclosed. The methods conveniently allow shorter administration time without the active ingredient coming out of solution as compared to presently available formulations. |
| Inventor(s): | Sundaram; Srikanth (Somerset, NJ) |
| Assignee: | EAGLE PHARMACEUTICALS, INC. (Woodcliff Lake, NJ) |
| Application Number: | 15/432,378 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 10,052,385 |
|
Patent Claim Types: see list of patent claims | Use; Composition; |
Drugs Protected by US Patent 10,052,385
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Eagle Pharms | BENDEKA | bendamustine hydrochloride | SOLUTION;IV (INFUSION) | 208194-001 | Dec 7, 2015 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | FOR THE TREATMENT OF PATIENTS WITH INDOLENT B-CELL NON-HODGKIN LYMPHOMA | ⤷ Sign Up | ||||
| Eagle Pharms | BENDEKA | bendamustine hydrochloride | SOLUTION;IV (INFUSION) | 208194-001 | Dec 7, 2015 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | FOR THE TREATMENT OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,052,385
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Canada | 2867295 | ⤷ Sign Up | |||
| Canada | 2867343 | ⤷ Sign Up | |||
| China | 104271135 | ⤷ Sign Up | |||
| China | 104302291 | ⤷ Sign Up | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
